Investments

A key component of the Novo Holdings strategy is to substantially increase our investing in life science companies in the coming years

Kasim Kutay, CEO, Novo Holdings

Our investment strategy

The overriding strategy of Novo Holdings is 1. to be a stable and supportive owner of the Novo Group, 2. to generate attractive long-term returns that allow us to both deliver an income to the Novo Nordisk Foundation and to grow the Investment Portfolio, 3. to allocate a significant portion of our funds to direct life science investing, where we can leverage our heritage and deep-rooted insights, 4. to invest, both through specialist portfolio managers and directly, across the asset classes including equities, fixed income and alternatives through Capital Investments, and 5. to invest for positive societal impact.

In relation to our Life Science Investments, we endeavour to:

  • invest in established private and public life science companies with a strong long-term potential, as executed by Principal Investments
  • invest in private and public growth companies requiring expansion capital, as executed by Growth Investments;
  • invest in private and public venture companies, as executed by Venture Investments;
  • create and build life science companies in Scandinavia, as executed by Seed Investments;

We have a long-term and flexible investment style. We can invest in private and public companies, take majority and minority positions and we can hold equity and debt. Furthermore, we aspire to bring more than capital to our investments by leveraging our deep-rooted life-science expertise and network.

Novo Holdings realised record Income and Investment Returns of DKK 37 billion in 2021, up from DKK 29 billion in 2020. This result is well balanced and based on a strong performance from both the Novo Group companies and our Investment Portfolio, with the latter generating a very satisfactory return of 15% for the year. Novo Holdings closed the year with a record DKK 697 billion in total assets, up from DKK 457 billion in 2020, with the Investment Portfolio alone increasing to a record DKK 182 billion, up from DKK 150 billion in 2020.

Responsible Investments at Novo Holdings

We aspire to become catalysts of change by investing in companies that – like Novo Holdings – believe that there are achievable solutions to the pressing challenges facing both humankind and our planet. Read more.

Responsible Investments at Novo Holdings

We aspire to become catalysts of change by investing in companies that – like Novo Holdings – believe that there are achievable solutions to the pressing challenges facing both humankind and our planet. Read more.

All teams
All regions
Alphabetically
  • 17 %

    Return on Capital Investments in 2021

  • 2 bn

    Deployed into life sciences in 2021